740 Heinz Avenue
2 articles with Kyverna Therapeutics
Kyverna Therapeutics Announces the Appointment of James Chung, M.D., Ph.D., as Chief Medical Officer
Dr. Chung brings nearly 20 years' experience as a leader in autoimmune disease drug development with expertise in rheumatology, autoimmunity, and immunology Company also names world's leading immunology experts to Scientific Advisory Board
BioSpace is proud to present its NextGen Bio “Class of 2021,” a list of up-and-coming life sciences companies in North America that recently launched.